Skip to main content
. 2024 Sep 12;10:60. doi: 10.1186/s40959-024-00262-w

Table 2.

Baseline cancer characteristics

Cancer type, n (%) Cancer therapy, n (%)
Doxorubicin 106 (47)
Breast cancer 99 (44) Cyclophosphamide 109 (48)
Multiple Myeloma 28 (12) Docetaxel 14 (6)
Lymphoma 20 (9) Carboplatin 30 (13)
Lung cancer 7 (3) Trastuzumab 34 (15)
Prostate cancer 7 (3) Pertuzumab 28 (12)
Colorectal cancer 8 (4) Paclitaxel 84 (37)
Osteosarcoma 14 (6) Flourouracil 14 (6)
Leukemia 3 (1) Bevacizumab 8 (4)
Other 35 (15) Radiation 60 (27)

n Number, SD Standard deviation